As Illumina stock bounces off a 10-year low, analysts see no quick fix

DNA sequencing company juggles leadership transition, questions about new product launch, and unwinding of a troubled acquisition

Related Keywords

Canaccord Genuity ,Kyle Mikson ,Jacob Thaysen ,Carl Icahn ,European Commission ,Mettler Toledo International Inc ,Illumina Inc ,European Court ,Agilent Technologies Inc ,Thermo Fisher Scientific Inc ,Novaseqx Series ,Mettler Toledo International ,Thermo Fisher Scientific ,Agilent Technologies ,Article Normal ,Biotechnology Services ,Machinery ,Healthcare Life Sciences ,Genomics ,Industrial Goods ,Financial Performance ,Analysts Amp 39 Comments Recommendations ,Share Price Movement Disruptions ,Ownership Changes ,Acquisitions Mergers Shareholdings ,New Products Services ,Acquisitions Mergers ,Corporate Actions ,Corporate Industrial News ,Divestments ,Products Services ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Ilmn ,Analysts Amp 39 Comments ,Recommendations ,Share Price Movement ,Disruptions ,Acquisitions ,Mergers ,Shareholdings ,New Products ,Services ,Corporate ,Industrial News ,Products ,Healthcare ,Life Sciences ,